Charles E. Odya

666 total citations
20 papers, 525 citations indexed

About

Charles E. Odya is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Charles E. Odya has authored 20 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Genetics and 7 papers in Oncology. Recurrent topics in Charles E. Odya's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers), Peptidase Inhibition and Analysis (7 papers) and Neuropeptides and Animal Physiology (5 papers). Charles E. Odya is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers), Peptidase Inhibition and Analysis (7 papers) and Neuropeptides and Animal Physiology (5 papers). Charles E. Odya collaborates with scholars based in United States and Canada. Charles E. Odya's co-authors include Ervin G. Erdös, T.A. Stewart, Theodore L. Goodfriend, Clara Peña, John M. Stewart, Fusao Hirata, Claude Gagnon, Susan J. Kelly, Martha Vaughan and Warren J. Strittmatter and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Charles E. Odya

20 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles E. Odya United States 13 255 239 120 114 111 20 525
W.H. Simmons United States 10 268 1.1× 120 0.5× 394 3.3× 300 2.6× 48 0.4× 17 599
Donna L. Pedicord United States 13 193 0.8× 76 0.3× 70 0.6× 66 0.6× 54 0.5× 16 509
Candace Strang United States 13 486 1.9× 127 0.5× 62 0.5× 85 0.7× 98 0.9× 17 724
Yumiko Moritani Japan 12 453 1.8× 33 0.1× 44 0.4× 144 1.3× 129 1.2× 16 725
X.K. Nguyen‐Le Canada 14 166 0.7× 286 1.2× 58 0.5× 156 1.4× 36 0.3× 22 427
Ian Fisher United States 6 190 0.7× 22 0.1× 197 1.6× 60 0.5× 100 0.9× 10 590
Ulrich Nielsch Germany 12 228 0.9× 20 0.1× 170 1.4× 200 1.8× 73 0.7× 14 620
Léonid Volkov Canada 12 242 0.9× 41 0.2× 45 0.4× 36 0.3× 48 0.4× 19 353
I S Fulcher United Kingdom 7 370 1.5× 34 0.1× 371 3.1× 467 4.1× 27 0.2× 8 647
Olga Zhdanova Russia 9 402 1.6× 49 0.2× 25 0.2× 42 0.4× 92 0.8× 30 675

Countries citing papers authored by Charles E. Odya

Since Specialization
Citations

This map shows the geographic impact of Charles E. Odya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Odya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Odya more than expected).

Fields of papers citing papers by Charles E. Odya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Odya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Odya. The network helps show where Charles E. Odya may publish in the future.

Co-authorship network of co-authors of Charles E. Odya

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Odya. A scholar is included among the top collaborators of Charles E. Odya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Odya. Charles E. Odya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Odya, Charles E., et al.. (1993). Immunoassays for des-Arg9-Bradykinin. Journal of Immunoassay. 14(4). 227–240. 2 indexed citations
2.
Odya, Charles E. & Che‐Hung Lee. (1990). Enzyme-linked immunosorbent assays for kinins using high-affinity monoclonal kinin antibodies. Biochemical Pharmacology. 40(2). 245–251. 4 indexed citations
3.
Ward, Patrick E., et al.. (1987). Kinin and angiotensin metabolism by purified renal post-proline cleaving enzyme. Biochemical Pharmacology. 36(19). 3187–3193. 29 indexed citations
4.
Odya, Charles E., et al.. (1987). Characterization of soluble bradykinin receptor-like binding sites. European Journal of Pharmacology. 134(1). 45–52. 16 indexed citations
5.
Odya, Charles E., Robert Dally, & Katy E. Georgiadis. (1987). Specific, high-affinity bradykinin binding by purified porcine kidney post-proline cleaving enzyme. Biochemical Pharmacology. 36(1). 39–49. 10 indexed citations
6.
7.
Rightsel, Wilton A., et al.. (1985). B2 bradykinin receptor-like binding in rat renomedullary interstitial cells. Life Sciences. 37(4). 331–338. 22 indexed citations
8.
Vavrek, Raymond J., et al.. (1984). Further studies of myometrial bradykinin receptor-like binding. Biochemical Pharmacology. 33(18). 2887–2892. 24 indexed citations
9.
Odya, Charles E., et al.. (1983). Interactions of kinins with angiotensin I converting enzyme (kininase II). Biochemical Pharmacology. 32(24). 3839–3847. 21 indexed citations
10.
Odya, Charles E., et al.. (1983). Development of a radioimmunoassay for [des-Arg9]-bradykinin. Biochemical Pharmacology. 32(2). 337–342. 18 indexed citations
11.
Odya, Charles E., et al.. (1983). Immunoreactive bradykinin and [des-Arg9]-bradykinin in low-renin essential hypertension--before and after treatment with enalapril (MK 421).. PubMed. 102(5). 714–21. 30 indexed citations
12.
Odya, Charles E. & Ervin G. Erdös. (1981). [38] Human prolylcarboxypeptidase. Methods in enzymology on CD-ROM/Methods in enzymology. 80 Pt C. 460–466. 19 indexed citations
13.
Gagnon, Claude, Susan J. Kelly, Vincent C. Manganiello, et al.. (1981). Modification of calmodulin function by enzymatic carboxyl methylation. Nature. 291(5815). 515–516. 91 indexed citations
14.
Odya, Charles E., Theodore L. Goodfriend, & Clara Peña. (1980). Bradykinin receptor-like binding studied with iodinated analogues. Biochemical Pharmacology. 29(2). 175–185. 50 indexed citations
15.
Odya, Charles E., et al.. (1980). Subcellular localization of lodinated human kidney α-d-mannosidase in rat liver: Association with subcellular fractions in vivo and in vitro. Biochemical Medicine. 24(3). 327–335. 1 indexed citations
16.
Odya, Charles E., Elizabeth R. Hall, & Carol J.G. Robinson. (1979). Radioimmunoassay for pig angiotensin I converting enzyme: A comparison of immunologic with enzymatic activity. Biochemical and Biophysical Research Communications. 86(3). 508–513. 7 indexed citations
17.
Odya, Charles E., Yehuda Levin, Ervin G. Erdös, & Carol J.G. Robinson. (1978). Soluble dextran complexes of Kallikrein, Bradykinin and enzyme inhibitors. Biochemical Pharmacology. 27(2). 173–179. 15 indexed citations
18.
Odya, Charles E., et al.. (1978). Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney.. Journal of Biological Chemistry. 253(17). 5927–5931. 129 indexed citations
19.
Odya, Charles E., Theodore L. Goodfriend, John M. Stewart, & Clara Peña. (1978). Aspects of bradykinin radioimmunoassay. Journal of Immunological Methods. 19(2-3). 243–257. 25 indexed citations
20.
Itskovitz, Harold D. & Charles E. Odya. (1971). Intrarenal Formation of Angiotensin I. Science. 174(4004). 58–59. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026